Expression patterns of CD168 correlate with the stage and grade of squamous cell carcinoma of head and neck

Jöhrens,Korinna; Anagnostopoulos,Ioannis; Dommerich,Steffen; Raguse,Jan Dirk; Szczepek,Agnieszka J.; Klauschen,Frederick; Stölzel,Katharina

doi:10.3892/mco.2017.1165

Expression patterns of CD168 correlate with the stage and grade of squamous cell carcinoma of head and neck

Authors:
- Korinna Jöhrens
- Ioannis Anagnostopoulos
- Steffen Dommerich
- Jan Dirk Raguse
- Agnieszka J. Szczepek
- Frederick Klauschen
- Katharina Stölzel
View Affiliations

Affiliations: Institute of Pathology, Charité‑Universitätsmedizin, Campus Charité Mitte, D-10117 Berlin, Germany, Department of Otorhinolaryngology, Head and Neck Surgery, Charité‑Universitätsmedizin, Campus Charité Mitte, D-10117 Berlin, Germany, Department of Oral and Maxillofacial Surgery, Charité‑Universitätsmedizin, Campus Charité Virchow-Klinikum, D-13353 Berlin, Germany
Published online on: February 13, 2017 https://doi.org/10.3892/mco.2017.1165
Pages: 597-602

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The receptor for hyaluronan-mediated motility CD168 is associated with the processes of oncogenesis and metastasis. The objective of the present study was to determine the possible association between the expression and distribution of CD168 and the tumor stage of head-and-neck squamous cell carcinoma (SCC). Formalin-fixed and paraffin-embedded tumor samples obtained from 100 patients during primary resection of SCC from the oral cavity, oropharynx, hypopharynx or larynx were included in the present study. The patients were divided into two risk groups: Low risk, representing the early stage of completely resected SCCs with good-to-moderate differentiation, and the high-risk group, representing the advanced stage SCCs with positive resection margins, vascular invasion or locoregional metastasis. All specimens were stained with a monoclonal antibody against CD168. Percentage and staining intensity of CD168-positive cells were scored, and their spatial distribution within the tumor nests was noted. The results obtained were correlated with the tumor stage. The quantification of CD168 expression revealed significant differences between the two risk groups (t-test, P=0.002), with higher scores in tumors resected from the high-risk SSC group compared with those from the low-risk group. In addition, in the high-risk group, the CD168-positive cells were present predominantly in the periphery (70.4%) of tumor nests, whereas in the low-risk group, only 56.6% were located there; however, this trend did not reach the level of statistical significance. Taken together, the results from the present study suggested that CD168 expression patterns could potentially be used as a predictor of tumor aggressiveness, and therefore they may be a prognostic factor in head-and-neck SCC.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
2	Gao J, Panizza B, Johnson NW, Coman S and Clough AR: Basic consideration of research strategies for head and neck cancer. Front Med. 6:339–353. 2012. View Article : Google Scholar : PubMed/NCBI
3	Gangane N, Chawla S, Anshu, Gupta SS and Sharma SM: Reassessment of risk factors for oral cancer. Asian Pac J Cancer Prev. 8:243–248. 2007.PubMed/NCBI
4	Accortt NA, Waterbor JW, Beall C and Howard G: Cancer incidence among a cohort of smokeless tobacco users (United States). Cancer Causes Control. 16:1107–1115. 2005. View Article : Google Scholar : PubMed/NCBI
5	Paz IB, Cook N, Odom-Maryon T, Xie Y and Wilczynski SP: Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer. 79:595–604. 1997. View Article : Google Scholar : PubMed/NCBI
6	Kreimer AR, Clifford GM, Boyle P and Franceschi S: Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review. Cancer Epidemiol Biomarkers Prev. 14:467–475. 2005. View Article : Google Scholar : PubMed/NCBI
7	Zaravinos A: An updated overview of HPV-associated head and neck carcinomas. Oncotarget. 5:3956–3969. 2014. View Article : Google Scholar : PubMed/NCBI
8	Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, et al: HPV Typing of Cancers Workgroup: US assessment of HPV types in cancers: Implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 107:djv0862015. View Article : Google Scholar : PubMed/NCBI
9	Grimm M, Schmitt S, Teriete P, Biegner T, Stenzl A, Hennenlotter J, Muhs HJ, Munz A, Nadtotschi T, König K, et al: A biomarker based detection and characterization of carcinomas exploiting two fundamental biophysical mechanisms in mammalian cells. BMC Cancer. 13:5692013. View Article : Google Scholar : PubMed/NCBI
10	Grimm M, Cetindis M, Lehmann M, Biegner T, Munz A, Teriete P and Reinert S: Apoptosis resistance-related ABCB5 and DNaseX (Apo10) expression in oral carcinogenesis. Acta Odontol Scand. 73:336–342. 2015. View Article : Google Scholar : PubMed/NCBI
11	Lynn BD, Li X, Cattini PA, Turley EA and Nagy JI: Identification of sequence, protein isoforms, and distribution of the hyaluronan-binding protein RHAMM in adult and developing rat brain. J Comp Neurol. 439:315–330. 2001. View Article : Google Scholar : PubMed/NCBI
12	Choudhary M, Zhang X, Stojkovic P, Hyslop L, Anyfantis G, Herbert M, Murdoch AP, Stojkovic M and Lako M: Putative role of hyaluronan and its related genes, HAS2 and RHAMM, in human early preimplantation embryogenesis and embryonic stem cell characterization. Stem Cells. 25:3045–3057. 2007. View Article : Google Scholar : PubMed/NCBI
13	Karamitopoulou E, Zlobec I, Panayiotides I, Patsouris ES, Peros G, Rallis G, Lapas C, Karakitsos P, Terracciano LM and Lugli A: Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer. Hum Pathol. 42:1888–1896. 2011. View Article : Google Scholar : PubMed/NCBI
14	Knüpfer MM, Poppenborg H, Hotfilder M, Kühnel K, Wolff JE and Domula M: CD44 expression and hyaluronic acid binding of malignant glioma cells. Clin Exp Metastasis. 17:71–76. 1999. View Article : Google Scholar : PubMed/NCBI
15	Assmann V, Gillett CE, Poulsom R, Ryder K, Hart IR and Hanby AM: The pattern of expression of the microtubule-binding protein RHAMM/IHABP in mammary carcinoma suggests a role in the invasive behaviour of tumour cells. J Pathol. 195:191–196. 2001. View Article : Google Scholar : PubMed/NCBI
16	Kong QY, Liu J, Chen XY, Wang XW, Sun Y and Li H: Differential expression patterns of hyaluronan receptors CD44 and RHAMM in transitional cell carcinomas of urinary bladder. Oncol Rep. 10:51–55. 2003.PubMed/NCBI
17	Schmitt A, Barth TF, Beyer E, Borchert F, Rojewski M, Chen J, Guillaume P, Gronau S, Greiner J, Möller P, et al: The tumor antigens RHAMM and G250/CAIX are expressed in head and neck squamous cell carcinomas and elicit specific CD8+ T cell responses. Int J Oncol. 34:629–639. 2009. View Article : Google Scholar : PubMed/NCBI
18	Shigeishi H, Fujimoto S, Hiraoka M, Ono S, Taki M, Ohta K, Higashikawa K and Kamata N: Overexpression of the receptor for hyaluronan-mediated motility, correlates with expression of microtubule-associated protein in human oral squamous cell carcinomas. Int J Oncol. 34:1565–1571. 2009. View Article : Google Scholar : PubMed/NCBI
19	Shigeishi H, Biddle A, Gammon L, Emich H, Rodini CO, Gemenetzidis E, Fazil B, Sugiyama M, Kamata N and Mackenzie IC: Maintenance of stem cell self-renewal in head and neck cancers requires actions of GSK3β influenced by CD44 and RHAMM. Stem Cells. 31:2073–2083. 2013. View Article : Google Scholar : PubMed/NCBI
20	Turley EA, Noble PW and Bourguignon LY: Signaling properties of hyaluronan receptors. J Biol Chem. 277:4589–4592. 2002. View Article : Google Scholar : PubMed/NCBI
21	Wang C, Entwistle J, Hou G, Li Q and Turley EA: The characterization of a human RHAMM cDNA: Conservation of the hyaluronan-binding domains. Gene. 174:299–306. 1996. View Article : Google Scholar : PubMed/NCBI
22	Telmer PG, Tolg C, McCarthy JB and Turley EA: How does a protein with dual mitotic spindle and extracellular matrix receptor functions affect tumor susceptibility and progression? Commun Integr Biol. 4:182–185. 2011. View Article : Google Scholar : PubMed/NCBI
23	Schlesinger-Raab AHU, Schubert-Fritschle G and Engel J: Epidemiologie der Kopf-Hals-TumorenKopf-Hals-Malignome Mast G. München: 2014
24	Woolgar JA and Triantafyllou A: Pitfalls and procedures in the histopathological diagnosis of oral and oropharyngeal squamous cell carcinoma and a review of the role of pathology in prognosis. Oral Oncol. 45:361–385. 2009. View Article : Google Scholar : PubMed/NCBI
25	Turley EA, Hossain MZ, Sorokan T, Jordan LM and Nagy JI: Astrocyte and microglial motility in vitro is functionally dependent on the hyaluronan receptor RHAMM. Glia. 12:68–80. 1994. View Article : Google Scholar : PubMed/NCBI
26	Turley EA, Austen L, Moore D and Hoare K: Ras-transformed cells express both CD44 and RHAMM hyaluronan receptors: Only RHAMM is essential for hyaluronan-promoted locomotion. Exp Cell Res. 207:277–282. 1993. View Article : Google Scholar : PubMed/NCBI
27	Laurent TC: Biochemistry of hyaluronan. Acta Otolaryngol Suppl. 442:7–24. 1987. View Article : Google Scholar : PubMed/NCBI
28	Niedworok C, Kretschmer I, Röck K, Vom Dorp F, Szarvas T, Hess J, Freudenberger T, Melchior-Becker A, Rübben H and Fischer JW: The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder. PLoS One. 8:e756812013. View Article : Google Scholar : PubMed/NCBI
29	Yamano Y, Uzawa K, Shinozuka K, Fushimi K, Ishigami T, Nomura H, Ogawara K, Shiiba M, Yokoe H and Tanzawa H: Hyaluronan-mediated motility: A target in oral squamous cell carcinoma. Int J Oncol. 32:1001–1009. 2008.PubMed/NCBI
30	Akiyama Y, Jung S, Salhia B, Lee S, Hubbard S, Taylor M, Mainprize T, Akaishi K, van Furth W and Rutka JT: Hyaluronate receptors mediating glioma cell migration and proliferation. J Neurooncol. 53:115–127. 2001. View Article : Google Scholar : PubMed/NCBI
31	Mendoza ES Rosa, Moreno E and Caguioa PB: Predictors of early distant metastasis in women with breast cancer. J Cancer Res Clin Oncol. 139:645–652. 2013. View Article : Google Scholar : PubMed/NCBI
32	Page AJ, Li A, Hestley A, Murray D, Carlson GW and Delman KA: Increasing Age Is Associated with Worse Prognostic Factors and Increased Distant Recurrences despite Fewer Sentinel Lymph Node Positives in Melanoma. Int J Surg Oncol. 2012:4569872012.PubMed/NCBI